Comparison of conventional resection to D3 lymphadenectomy in right-sided colon cancer: A retrospective cohort study.

Colon cancer D3 Lymphadenectomy Right colectomy Survival

Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
20 Aug 2024
Historique:
received: 06 07 2024
revised: 08 08 2024
accepted: 19 08 2024
medline: 24 8 2024
pubmed: 24 8 2024
entrez: 23 8 2024
Statut: aheadofprint

Résumé

Lymphadenectomy during right hemicolectomy for colon cancer varies between the U.S. and Japan. Patients undergoing right hemicolectomy for non-metastatic right-sided colon cancer between 2010 and 2019 ​at U.S. and Japanese institutions were compared. Outcomes included survival, pathologic findings, and postoperative complications. 319 American patients (57 ​% female, mean age 70 years) underwent conventional resection and 308 Japanese patients (52 ​% female, mean age 70 years) underwent extended dissection. The conventional group underwent more laparotomies (26.6 ​% vs. 8.4 ​%, p ​< ​0.001), had more poorly differentiated histology (31.7 ​% vs. 11.0 ​%, p ​< ​0.01), lower lymph node yield (M ​= ​27 ​± ​11 vs. M ​= ​32 ​± ​14, p ​< ​0.001), and more 30-day readmissions (31 vs. 5, p ​< ​0.001). Adjusting for demographics, pathology, perioperative outcomes, and adjuvant chemotherapy, extended lymphadenectomy improved disease-free survival (HR 0.50; 95 ​% CI, 0.31-0.80; p ​= ​0.004), but not overall survival (HR 0.98; 95 ​% CI, 0.95-1.02; p ​= ​0.14). Extended lymphadenectomy for right sided-colon cancer improves disease-free, but not overall, survival among Japanese patients.

Sections du résumé

BACKGROUND BACKGROUND
Lymphadenectomy during right hemicolectomy for colon cancer varies between the U.S. and Japan.
METHODS METHODS
Patients undergoing right hemicolectomy for non-metastatic right-sided colon cancer between 2010 and 2019 ​at U.S. and Japanese institutions were compared. Outcomes included survival, pathologic findings, and postoperative complications.
RESULTS RESULTS
319 American patients (57 ​% female, mean age 70 years) underwent conventional resection and 308 Japanese patients (52 ​% female, mean age 70 years) underwent extended dissection. The conventional group underwent more laparotomies (26.6 ​% vs. 8.4 ​%, p ​< ​0.001), had more poorly differentiated histology (31.7 ​% vs. 11.0 ​%, p ​< ​0.01), lower lymph node yield (M ​= ​27 ​± ​11 vs. M ​= ​32 ​± ​14, p ​< ​0.001), and more 30-day readmissions (31 vs. 5, p ​< ​0.001). Adjusting for demographics, pathology, perioperative outcomes, and adjuvant chemotherapy, extended lymphadenectomy improved disease-free survival (HR 0.50; 95 ​% CI, 0.31-0.80; p ​= ​0.004), but not overall survival (HR 0.98; 95 ​% CI, 0.95-1.02; p ​= ​0.14).
CONCLUSIONS CONCLUSIONS
Extended lymphadenectomy for right sided-colon cancer improves disease-free, but not overall, survival among Japanese patients.

Identifiants

pubmed: 39178599
pii: S0002-9610(24)00463-X
doi: 10.1016/j.amjsurg.2024.115911
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115911

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors confirm that this manuscript has not been published elsewhere and is not under consideration by another journal.

Auteurs

Praachi Raje (P)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: praje@mgh.harvard.edu.

Swati Sonal (S)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

Hiroko Kunitake (H)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

David L Berger (DL)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

Grace C Lee (GC)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

Rocco Ricciardi (R)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

Satoru Morita (S)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Kohei Shigeta (K)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Koji Okabayashi (K)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Robert N Goldstone (RN)

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

Classifications MeSH